Fundz

Microbiotica raises £36M ($48M) in Series C to advance pipeline into Phase 2 clinical development.

PRIVATEOct 16, 2026

Amount Raised

$48 Million

Round Type

Series C

CambridgeBiotechnologyHealth Care

Investors

Seventure PartnersFlerie InvestCambridge Innovation CapitalIP GroupTencentBritish Business Bank

Description

Microbiotica has secured £36 million ($48 million) in Series C financing to accelerate its drug development pipeline into Phase 2 clinical trials. The funding will support the company's efforts to advance its therapeutic candidates through further clinical development stages. This Series C round represents a significant milestone in Microbiotica's journey to bring its pipeline programs to market.

Quick answer

Microbiotica raised $48 Million in a Series C round, dated October 16, 2026. Investors: Seventure Partners, Flerie Invest, Cambridge Innovation Capital, IP Group, Tencent and British Business Bank. Microbiotica is based in Cambridge, Maryland, United States.

How much did Microbiotica raise?
Microbiotica raised $48 Million in a Series C round on October 16, 2026.
Who invested in Microbiotica?
Seventure Partners, Flerie Invest, Cambridge Innovation Capital, IP Group, Tencent and British Business Bank are named as investors in this round.
What does Microbiotica do?
Microbiotica is a leading player in the field of microbiome-based therapeutics, biomarkers and targets.
Where is Microbiotica based and how big is it?
Microbiotica is based in Cambridge, Maryland, United States. Fundz records about 49 employees.
Who are the decision-makers at Microbiotica?
Fundz holds 2 contacts at Microbiotica, including the Chief Medical Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Microbiotica that raised within 45 days of this round, from Fundz verified event records.

  • Celosia Therapeutics raised $1.3M (Grant) on November 18, 2026.
  • Onward Therapeutics SA raised $28M (Series B) on November 17, 2026.
  • Soombit AI raised $9M (Series A) on November 17, 2026.
  • VETmAb Biosciences raised an undisclosed amount on November 17, 2026.
  • Commit Biologics raised $60M (Seed) on November 17, 2026.
  • AstraNu raised $3.5M (Seed) on November 17, 2026.

Who to call at Microbiotica, and when

A new round usually means Microbiotica is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Microbiotica raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Microbiotica, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Microbiotica. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Microbiotica

Location

Cambridge, Maryland, United States

About

Microbiotica is a leading player in the field of microbiome-based therapeutics, biomarkers and targets. The Company is building a growing pipeline of differentiated products based on high quality clinical datasets and unique bacterial signatures that drive biology, identified by its proprietary platform. Consisting of the leading microbiome Reference Genome Database, Culture Collection, mass culturing technology (Personalised Bacterial Bank) and proprietary AI tools, Microbiotica’s platform enables unrivalled strain-level microbiome analysis linked to patient phenotypes. The Company’s current therapeutic areas of focus are immuno-oncology and IBD and it has established major clinical and academic partnerships in these areas. Spun out of the Sanger Institute in 2016, the Company is based at Chesterford Research Park near Cambridge, UK. Microbiotica’s investor syndicate includes British Patient Capital, Cambridge Innovation Capital, Flerie Invest, IP Group plc, Seventure Partners, and Tencent. For more information, please visit www.microbiotica.com, LinkedIn and Twitter.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Microbiotica raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsRobert T., Chief Medical Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Microbiotica's next move

See what Strategic adds

Microbiotica raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.